ARRY
Array Biopharma Inc
ARRY
ARRY
Delisted
ARRY was delisted on the 29th of July, 2019.
236 hedge funds and large institutions have $3B invested in Array Biopharma Inc in 2018 Q4 according to their latest regulatory filings, with 57 funds opening new positions, 74 increasing their positions, 74 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0% more repeat investments, than reductions
Existing positions increased: 74 | Existing positions reduced: 74
4% less capital invested
Capital invested by funds: $3.11B → $3B (-$111M)
Holders
236
Holding in Top 10
9
Calls
$31.1M
Puts
$12.4M
Top Buyers
| 1 | +$93.2M | |
| 2 | +$65.4M | |
| 3 | +$26.4M | |
| 4 |
Franklin Resources
San Mateo,
California
|
+$21.7M |
| 5 |
Goldman Sachs
New York
|
+$19.8M |
Top Sellers
| 1 | -$73.1M | |
| 2 | -$23.9M | |
| 3 | -$22M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$10.5M |
| 5 |
Morgan Stanley
New York
|
-$9.79M |